Impact of an HPV diagnosis on the psychosexual sphere

Abstract

We aimed to evaluate the psychosexual impact of being diagnosed with human papillomavirus (HPV). A cross-sectional study was conducted to assess the anxiety and depression levels and sexual functions in women with and without HPV between March and May 2021. Beck anxiety inventory (BAI), the Beck depression inventory (BDI), and the Libido scoring system scales (LSSS) were used as scales. A total of 575 respondents were included; 292 (50.2%) HPV-negative, and 283 (49.8%) HPV-positive, of whom 170 (60,1%) had high risk HPV genotypes 16/18 and 113 (39,9%) had non-16/18 high risk HPV-positive patients. There was no significant association between HPV-negative and HPV-positive patients in terms of sociodemographic characteristics. While 21.6% of the HPV-positive group experienced masturbation, it was 15.1% in the HPV-negative group (p=0.044). While severe depression was 4.9% in HPV-positive women, this rate was 1.4% in HPV-negative women (p=0.002). The present study showed that being diagnosed with HPV made a significant difference in sexual function, except for sexual interest, but increased anxiety and depression scores. Sexual dysfunction following an HPV diagnosis cannot be explained solely by depression and anxiety.

Keywords

• Anxiety
• depression
• Human papillomavirus (HPV)
• sexual function

References

1. 1. Centers CDC. Genital HPV Infection-Fact Sheet. STD Fact Sheet Internet. 2017. [Cited 10 Dec 2021.] Available from URL: https://www.cdc.gov/std/hpv/stdfact-hpv.htm
2. 2. Tovar JM, Bazaldua OV, Vargas L, Reile E. Human papillomavirus, cervical cancer, and the vaccines. Postgrad Med. 2008;120(2):79-84.
3. 3. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001;285(23):2995-3002.
4. 4. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048-1056.
5. 5. Cuschieri KS, Cubie HA. The role of human papillomavirus testing in cervical screening. J Clin Virol. 2005;32 Suppl 1:S34-S42.
6. 6. O'Connor M, Costello L, Murphy J, Prendiville W, Martin CM, O'Leary JJ, et al. 'I don't care whether it's HPV or ABC, I just want to know if I have cancer.' Factors influencing women's emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study. BJOG. 2014;121(11):1421-1429.
7. 7. Lin H, Jeng CJ, Wang LR. Psychological responses of women infected with cervical human papillomavirus: a qualitative study in Taiwan. Taiwanese J Obstet Gynecol. 2011;50(2):154-158.
8. 8. Kahn JA, Slap GB, Bernstein DI, Kollar LM, Tissot AM, Hillard PA, et al. Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results. J Womens Health (Larchmt). 2005;14(7):650-659. 9. McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect. 2006;82(2):169‐174.

9. 10. Maggino T, Casadei D, Panontin E, Fadda E, Zampieri MC, Donà MA, et al. Impact of an HPV diagnosis on the quality of life in young women. Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S175-179.
10. 11. Foster L, Byers E. Predictors of the sexual well-being of individuals diagnosed with Herpes and Human Papillomavirus. Arch Sex Behav. 2014;45(2):403–414.
11. 12. Sakin Ö, Uzun SB, Koyuncu K, Giray B, Akalın EE, Anğın AD. Cervix human papilloma virus positivity: Does it cause sexual dysfunction? Turk J Obstet Gynecol. 2019;16(4):235-41.
12. 13. Ulusoy M, Şahin N, Erkman H. Turkish version of the beck anxiety inventory: psychometric properties. Journal of Cognitive Psychotherapy. 1998:12;28–35.
13. 14. Hisli N. Beck Depresyon Envanteri’nin Geçerliği Üzerine Bir Çalışma. Psikoloji Dergisi. 1988:6;118–126.
14. 15. Api M, Api O, Görgen H, Çetin A, Yayla M. New diagnostic instrument for sexual function assessment in menopausal women: Libido scoring system. J Turk Ger Gynecol Assoc. 2005;6:24-29.
15. 16. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.
16. 17. Bennett KF, Waller J, Ryan M, Bailey JV, Marlow LAV. The psychosexual impact of testing positive for high-risk cervical human papillomavirus (HPV): A systematic review. Psychooncology. 2019;28(10):1959-1970.
17. 18. Kitchener HC, Fletcher I, Roberts C, Wheeler P, Almonte M, Maguire P. The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial. Int J Gynecol Cancer. 2008;18(4):743-748.
18. 19. Reed BD, Ruffin MT, Gorenflo DW, Zazove P. The psychosexual impact of human papillomavirus cervical infections. J Fam Pract. 1999;48(2):110-116.
19. 20. Ferenidou F, Salakos N, Vaidakis N, Paltoglou G, Bakalianou K, Papadimitriou G, et al. The impact of HPV diagnosis on women's sexual and mental health: preliminary findings. Clin Exp Obstet Gynecol. 2012;39(1):79-82.
20. 21. McBride E, Tatar O, Rosberger Z, Rockliffe L, Marlow LAV, Moss-Morris R, et al. Emotional response to testing positive for human papillomavirus at cervical cancer screening: a mixed method systematic review with meta-analysis. Health Psychol Rev. 2021;15(3):395-429.
21. 22. Alay I, Kaya C, Karaca I, Yildiz S, Baghaki S, Cengiz H, et al. The effect of being diagnosed with human papillomavirus infection on women's sexual lives. J Med Virol. 2020;92(8):1290-1297.
22. 23. Mercan R, Mercan S, Durmaz B, Sur H, Kilciksiz CM, Kacar AS, et al. Sexual dysfunction in women with human papilloma virus infection in the Turkish population. J Obstet Gynaecol. 2019;39(5):659-663.
23. 24. Johnson CY, Sharp L, Cotton SC, Harris CA, Gray NM, Little J, et al. Human papillomavirus infection and anxiety: analyses in women with low-grade cervical cytological abnormalities unaware of their infection status. PLoS One. 2011;6(6):e21046.